Related Experiment Video
Updated: Nov 7, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Atypical Reye syndrome: three cases of a problem that pediatricians should consider and remember
Serena Ferretti1, Antonio Gatto2, Antonietta Curatola3
1Department of Woman and Child Health and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy. serena.ferretti01@icatt.it.
Insights
Reye syndrome is a rare metabolic disorder in children, often following viral infections. This study highlights atypical cases, emphasizing diagnostic challenges and the need for increased awareness in pediatric critical care.
Area of Science:
- Pediatric critical care medicine
- Metabolic disorders
- Neurology
Background:
- Reye syndrome is a rare acquired metabolic disorder in children, typically following viral infections.
- Its pathogenesis involves mitochondrial dysfunction leading to liver and brain issues.
- Clinical presentation includes vomiting, liver dysfunction, and acute encephalopathy.
Purpose of the Study:
- To describe three cases of Reye syndrome with atypical features.
- To highlight diagnostic challenges and increase awareness of the condition.
- To analyze factors influencing prognosis and treatment.
Main Methods:
- Case report analysis of three children with Reye syndrome.
- Review of clinical features, laboratory findings, and neurological examinations.
- Assessment of diagnostic criteria and therapeutic interventions.
Main Results:
- Three cases presented with atypical features, including no intake of trigger substances and transient hematological changes.
- Observed dissociation between hepatic dysfunction, severe EEG changes, and mild neurological impairment.
- Metabolic acidosis was consistently detected, but diagnostic criteria remain non-specific.
Conclusions:
- Reye syndrome diagnosis can be challenging, particularly in atypical presentations.
- Increased awareness and understanding of these variations are crucial for timely diagnosis and management.
- Prognosis depends on disease stage and promptness of intensive care.
Introduction:
Reye syndrome is a rare acquired metabolic disorder appearing almost always during childhood. Its aetiopathogenesis, although controversial, is partially understood. The classical disease is typically anticipated by a viral infection with 3-5 days of well-being before the onset of symptoms, while the biochemical explanation of the clinical picture is a mitochondrial metabolism disorder, which leads to a metabolic failure of different tissues, especially the liver. Hypothetically, an atypical response to the preceding viral infection may cause the syndrome and host genetic factors and different exogenous agents, such as toxic substances and drugs, may play a critical role in this process. Reye syndrome occurs with vomiting, liver dysfunction and acute encephalopathy, characterized by lack of inflammatory signs, but associated with increase of intracranial pressure and brain swelling. Moreover, renal and cardiac dysfunction can occur. Metabolic acidosis is always detected, but diagnostic criteria are not specific. Therapeutic strategies are predominantly symptomatic, in order to manage the clinical and metabolic dysfunctions.
Case Reports:
We describe three cases of children affected by Reye syndrome with some atypical features, characterized by no intake of potentially trigger substances, transient hematological changes and dissociation between hepatic metabolic impairment, severe electroencephalographic slowdown and slightly altered neurological examination.
Conclusions:
The syndrome prognosis is related to the stage of the syndrome and the rapidity and the adequateness of intensive care treatments. The analysis of the patients leads to a greater awareness of the difficult diagnosis of this not well completely known syndrome.
More Related Videos
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Factors Affecting Drug Response: Overview